19th Annual New York GU Cancers Congress™

Registration and Breakfast

Hot Seat™: Who Will Face the Fire? Prostate Cancer

From PSA to ctDNA and Beyond: Evolving Biomarkers in Early Detection of Prostate Cancer

Imaging Innovations in Prostate Cancer: AI-Enhanced MRI and Ultrasound Fusion for Detection, Biopsy, and Beyond

Neuroendocrine Prostate Cancer: Spectrum, Recognition, and Management Implications

MXF: Treatment Intensification in mHSPC: Doublet vs Triplet Therapy

Local Therapy in mHSPC: Radiotherapy, Surgery, and Emerging Strategies

Optimizing Outcomes in mHSPC: Patient Selection, Supportive Care, and Survivorship

CRPC Today and Tomorrow: Overcoming Barriers and Advancing Therapeutic Frontiers

Beyond AR: Genetic and Epigenetic Drivers of mCRPC

Sequencing Strategies in mCRPC: ARPIs, Taxanes, and Emerging Agents

DDR Pathways in Advanced Prostate Cancer: Trials, Testing, and Therapeutic Strategies

Beyond BRCA and PSMA: Expanding the Precision Medicine Toolkit in Prostate Cancer

Symposium: PSMA in Focus: Imaging, Radioligand Therapy, and Next-Generation Strategies in Prostate Cancer

Hot Seat™: Who Will Face the Fire? Bladder and Renal Cancer

Biomarkers and Precision Oncology in Urothelial Carcinoma: From Bench to Bedside

MXF: Perioperative Strategies in MIBC — Surgery, Radiation, or Systemic Intensification?

Frontline Therapy in Advanced/Metastatic UC

Beyond EV Pembro: ADCs and Novel Approaches

Clear Cell vs Non–Clear Cell RCC: Biology and Clinical Implications

Surgical Management in RCC: Evolving Standards

Systemic Therapy for Advanced RCC: Current Landscape

The Future of RCC: Novel Agents and Precision Strategies

Challenging Case Debates Panel Discussion With Q&A